Anti‐tumor necrosis factor‐α monotherapy versus combo therapy with immunosuppressant in pediatric inflammatory bowel disease: A real‐life study
Combination therapy reduced overall anti-TNF-α failure in CD children, but not in UC patients. Additionally, a proactive approach was associated with increased anti-TNF-α durability.
Authors
- Caterina Strisciuglio (ORCID: https://orcid.org/0000-0002-9005-6571)
- Elena Scarpato (ORCID: https://orcid.org/0000-0003-3145-6206)
- Erasmo Miele (ORCID: https://orcid.org/0000-0003-4498-7305)
- Flora Fedele
- Annamaria Staiano (ORCID: https://orcid.org/0000-0003-0586-1339)
- Massimo Martinelli (ORCID: https://orcid.org/0000-0003-2152-747X)
Institutions
- University of Campania "Luigi Vanvitelli" (IT)
- University of Naples Federico II (IT)
Publication Details
- Journal
- Journal of Pediatric Gastroenterology and Nutrition
- Published
- 2025-11-20
- DOI
- https://doi.org/10.1002/jpn3.70280
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00